YPR203W is a yeast genomic locus on chromosome XVI, annotated as a non-essential gene with no characterized molecular function in the Saccharomyces Genome Database (SGD). Antibodies targeting yeast proteins typically follow nomenclature conventions such as:
Gene name: YPR203W
Protein name: Hypothetical protein YPR203W
Applications: Localization studies, knockout validation, or interaction mapping
While no YPR203W-specific antibodies are documented, the following table extrapolates expected properties based on antibody engineering principles from the search results :
The lack of YPR203W-specific antibodies aligns with broader challenges in antibody development for hypothetical proteins, as highlighted in recent studies :
Antigen design: Requires recombinant protein expression or peptide synthesis (≥8 kDa) .
Validation: Relies on knockout strains or orthogonal methods (e.g., tagged proteins) .
Commercial viability: Low demand for non-essential yeast proteins reduces commercial interest .
For researchers investigating YPR203W, the following approaches are advised based on current methodologies :
Epitope tagging: CRISPR-based insertion of HA, FLAG, or GFP tags.
Transcriptional analysis: RNA-seq or qPCR to study expression patterns.
Homology modeling: Predict function using AlphaFold2 (UniProt: P40470).
YPR203W is a Saccharomyces cerevisiae gene encoding a protein of currently unknown function. According to expression profiling data, YPR203W shows a 2.0-fold change in expression under certain experimental conditions . Developing antibodies against this protein is critical for characterizing its function through techniques such as Western blotting, immunoprecipitation, and localization studies. Since YPR203W appears in datasets alongside genes with known stress responses (such as FMP16 and HSP26), researchers are particularly interested in its potential role in cellular stress response pathways .
Proper validation requires multiple control experiments. Primary controls should include YPR203W deletion strains as negative controls and strains overexpressing tagged versions as positive controls. For Western blot applications, include constitutively expressed proteins such as Mcm2 as loading controls . When performing immunoprecipitation experiments, pre-incubate your antibody with beads in phosphate-buffered saline containing 5 mg/ml BSA for at least 2 hours, following protocols established for other yeast proteins . For genome-wide localization studies, parallel IgG controls are essential for establishing background signals and calculating accurate P-values.
Sample preparation significantly impacts antibody detection sensitivity. Two primary methods have demonstrated effectiveness: grinding in liquid nitrogen or lysis with glass beads . For Western blotting applications with YPR203W antibodies, transfer to PVDF membranes has shown superior results compared to nitrocellulose . When conducting tandem affinity purification (TAP), prepare whole cell extracts by grinding in liquid nitrogen from cultures grown to an A600 of approximately 2, similar to protocols established for other yeast proteins with unknown functions .
For immunoprecipitation of YPR203W, several protocol optimizations are recommended based on successful approaches with other yeast proteins. Pre-incubate antibodies with pan-mouse IgG Dynal beads in phosphate-buffered saline containing 5 mg/ml BSA for a minimum of 2 hours . Perform immunoprecipitations in triplicate to ensure reproducibility. When analyzing results, implement an error model similar to those used in Rosetta Resolver for calculating P-values . For genome-wide occupancy studies, express results as the ratio of fluorophore intensities from immunoprecipitated chromatin fragments versus input chromatin fragments, with a P-value threshold of 0.02 and intensity ratio >1.0 for inclusion in final datasets .
Detecting post-translational modifications requires multiple complementary techniques. Begin with baseline Western blotting to establish the apparent molecular weight of YPR203W. Migration shifts in SDS-PAGE could indicate modifications. For definitive analysis, immunoprecipitate YPR203W using validated antibodies and perform mass spectrometry. When conducting densitometric scanning of Western blots, software such as AlphaImager 3400 has proven effective for quantifying relative protein levels and detecting modified forms . Consider developing modification-specific antibodies if particular modifications are consistently observed.
For genome-wide localization studies with YPR203W antibodies, follow protocols similar to those established for myc-tagged proteins in yeast . Perform immunoprecipitations in triplicate with anti-myc antibody (such as 9E11) and pan-mouse IgG Dynal beads. Analyze correlations between genomic occupancy and transcriptional frequency to determine if YPR203W associates with actively transcribed regions, as observed with other transcriptional regulators . Look for positive correlations with known transcription factors like Fhl1 (p = 2.2 × 10^-7) and Rap1 (p = 1.1 × 10^-5) to identify potential functional relationships .
Given that YPR203W appears in datasets alongside known stress-responsive genes like HSP26 (heat shock protein with chaperone activity) and DDR2 (multistress response protein) , design experiments that expose yeast to various stressors. Test heat shock (37-42°C), osmotic stress (high salt), oxidative stress (H₂O₂), nutrient limitation, and ethanol stress (4% ethanol, as used in tra1-L3733A studies) . For each condition, measure YPR203W protein levels via Western blotting and compare with known stress markers. Conduct parallel experiments in deletion strains of stress-response pathway components to identify potential regulatory relationships.
To investigate potential interactions with transcriptional machinery, implement a multi-faceted approach. First, perform tandem affinity purification (TAP) using protocols established for other yeast proteins . Follow with mass spectrometry to identify interaction partners. Conduct ChIP experiments to determine if YPR203W associates with chromatin, analyzing correlation with transcriptional frequency as performed for Tra1 . Examine potential correlations with transcription factors like Fhl1 and Rap1 that associate with actively transcribed genes. Additionally, investigate whether YPR203W associates with known transcriptional complexes like SAGA or NuA4 .
To investigate functional redundancy, create single and combined deletion strains. Analyze growth phenotypes under various conditions, particularly focusing on stressors that affect expression of YPR203W (such as ethanol) . Perform Western blotting on single deletion strains to determine if related proteins show compensatory expression changes. Consider synthetic genetic array (SGA) analysis to identify genetic interactions systematically. For proteins showing potential redundancy, conduct epistasis experiments by overexpressing one protein in the background of another's deletion and measuring phenotypic rescue.
Discrepancies between mRNA and protein levels often reflect post-transcriptional regulation. First, verify the technical aspects of both assays: for RT-qPCR, check primer specificity and RNA quality; for Western blotting, confirm antibody specificity and loading controls. Next, consider biological explanations by designing time-course experiments to detect potential delays between transcription and translation. The 2.0-fold change observed in YPR203W mRNA expression might not translate directly to protein levels due to differences in protein stability and turnover rates.
For genome-wide localization studies using YPR203W antibodies, implement statistical approaches similar to those used with other chromatin-associated proteins. Calculate P-values using established error models like those in Rosetta Resolver . For chromatin immunoprecipitation data, express genome-wide occupancy as the ratio of fluorophore intensities from immunoprecipitated versus input chromatin fragments, applying a P-value threshold of 0.02 and intensity ratio >1.0 for final datasets . Perform hierarchical cluster analysis to compare expression profiles with other mutations or conditions, similar to analyses conducted for tra1 mutations .
If cross-reactivity occurs, implement systematic troubleshooting. First, verify the specificity using YPR203W deletion strains as negative controls. Perform peptide competition assays by pre-incubating the antibody with purified antigenic peptides. Optimize blocking conditions using 5 mg/ml BSA in phosphate-buffered saline, similar to protocols used for other yeast antibodies . Consider alternative antibody production methods if persistent cross-reactivity occurs, potentially focusing on unique regions of YPR203W identified through sequence alignment with related proteins.
For investigating protein-protein interactions, implement tandem affinity purification (TAP) protocols as described for other yeast proteins . Prepare whole cell extracts by grinding in liquid nitrogen from cultures grown to appropriate density (A600 ~2). Perform immunoprecipitation with YPR203W antibodies pre-incubated with beads in 5 mg/ml BSA solution . Analyze co-precipitated proteins by mass spectrometry or Western blotting with antibodies against suspected interaction partners. To capture transient or weak interactions, consider crosslinking approaches before cell lysis.
To study potential regulated degradation, design cycloheximide chase experiments comparing YPR203W stability under normal and stress conditions. Track protein levels via Western blotting using techniques established for other yeast proteins . Compare degradation kinetics in wild-type versus proteasome or autophagy pathway mutants. For quantification, implement densitometric scanning methods with appropriate software such as AlphaImager 3400 . Look for potential ubiquitination by immunoprecipitating YPR203W and blotting with anti-ubiquitin antibodies, or by mass spectrometry analysis of purified protein.
Suppressor analysis provides valuable functional insights. Generate a library of random intragenic suppressors similar to approaches used for tra1-L3733A . Screen for suppressors that restore growth under conditions where YPR203W function is critical. Use YPR203W antibodies to confirm protein expression and stability of suppressor variants via Western blotting. Map suppressor mutations to identify functional domains. For comprehensive analysis, combine with site-directed mutagenesis of conserved residues and assess effects on protein function, stability, and interactions using established immunological techniques .